Sophie X. Deng, MD, PhD, FARVO, has stepped into the role as the new 2025-2026 Association for Research and Ophthalmology (ARVO) president. Deng has been part of ARVO for more than 20 years, is a ...

The pivotal phase 3 clinical trial is the first of 2 that will evaluate the use of DURAVYU for the treatment of wet age-related macular degeneration.

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

ARVO Foundation to give Subrata Batabyal, PhD, 2025 Carl Camras Translational Research Award Published: April 17th 2025 | Updated: May 1st 2025 RWC 2025: Companies to share data at meeting in Fort ...